Abstract
Bone marrow derived human Mesenchymal Stem Cells (hMSCs) are an attractive candidate for regenerative medicine. However, their harvest can be invasive, painful, and expensive, making it difficult to supply the enormous amount of pure hMSCs needed for future allogeneic therapies. Because of this, a robust method of scaled bioreactor culture must be designed to supply the need for high purity, high density hMSC yields. Here we test a scaled down model of a novel bioreactor consisting of an unsubmerged 3D printed Polylactic Acid (PLA) lattice matrix wetted by culture media. The growth matrix is uniform, replicable, and biocompatible, enabling homogenous cell culture in three dimensions. The goal of this study was to prove that hMSCs would culture well in this novel bioreactor design. The system tested resulted in comparable stem cell yields to other cell culture systems using bone marrow derived hMSCs, while maintaining viability (96.54% ±2.82), high purity (>98% expression of combined positive markers), and differentiation potential.
Funder
Fenton Bioprocessing Leadership
Publisher
Public Library of Science (PLoS)
Reference63 articles.
1. Department of Health and Human Services. Regenerative Medicine [Internet]. 2006 [cited 2019 Apr 9]. Available from: https://stemcells.nih.gov/sites/all/themes/stemcells_theme/stemcell_includes/Regenerative_Medicine_2006.pdf.
2. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review;W Faiella;Stem Cells Int,2016
3. Clinical Trials with Mesenchymal Stem Cells: An Update;T Squillaro;Cell Transplant,2016
4. Tunable Surface Repellency Maintains Stemness and Redox Capacity of Human Mesenchymal Stem Cells;DA Balikov;ACS Appl Mater Interfaces,2017
5. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC;R Hass;Cell Commun Signal,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献